A Study To Examine The Effects Of PF-04958242 On Ketamine-Induced Cognitive Impairment In Healthy Volunteers
| Status: | Completed |
|---|---|
| Conditions: | Cognitive Studies, Schizophrenia |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 21 - 45 |
| Updated: | 3/1/2014 |
| Start Date: | November 2012 |
| End Date: | June 2014 |
| Contact: | Pfizer CT.gov Call Center |
| Phone: | 1-800-718-1021 |
A Randomized, Subject And Investigator Blinded, Sponsor Open Placebo Controlled, 2 Way, Crossover Phase 1b Study To Examine The Effects Of PF-04958242 On Ketamine Induced Cognitive Impairment In Healthy Male Volunteers
To assess if PF-04958242 can attenuate the ketamine-induced cognitive impairment in verbal
learning and memory, episodic memory and spatial working memory in healthy volunteers.
learning and memory, episodic memory and spatial working memory in healthy volunteers.
Inclusion Criteria:
- Healthy male subjects 21 - 45 years old.
- Able to read and write English as primary language.
- Subjects who are willing to comply with study procedures.
Exclusion Criteria:
- History of any substance abuse or dependence disorder meeting DSM-IV criteria and/or
by SCID-NP within the past 12 months, with the exception of nicotine.
- Known sensitivity to ketamine
- Any history of DSM-IV Axis I psychiatric disorders, determined by SCID-NP interview
or diagnoses in the view of the investigator.
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials